Daily Health Headlines

Mouse Study Offers Hope for Vaccine Against Chlamydia

👤by Dennis Thompson 0 comments 🕔Friday, July 22nd, 2016

THURSDAY, July 21, 2016 (HealthDay News) -- A new Canadian study with mice suggests there is hope for a vaccine to protect against chlamydia, a common, sexually transmitted infection that can render young women infertile if left untreated.

The vaccine works by interrupting the process by which chlamydia infects host cells, said senior researcher James Mahony, a professor of pathology and molecular medicine at McMaster University in Hamilton, Ontario.

In female lab mice, the vaccine essentially halted the spread of chlamydia and prevented sterility. However, it should be stressed that animal research often fails to pan out in humans, so further research is needed.

"The vaccine reduced the amount of bacteria in the vagina by about 95 percent" in the rodents, Mahony said. "More importantly, it reduced the pathology [disease] in the fallopian tubes by about 85 percent, which is quite remarkable. That's probably enough to prevent infertility."

There currently is no approved vaccine to protect against chlamydia, he added.

Chlamydia causes infertility by damaging the fallopian tubes, the female reproductive structure in which fertilization occurs, Mahony said. A blockage in the tubes can prevent a man's sperm from reaching a woman's egg.

Most women -- as many as eight out of 10 -- do not show any symptoms when they are infected with chlamydia, Mahony said.

"Women who get infected but don't know they are infected don't get a diagnosis, don't get antibiotics, don't get treated, [and] run the risk of tubal infertility," he said.

To develop the vaccine, Mahony and his colleagues focused on the protein secretion system used by chlamydia to invade cells.

Chlamydia can only grow inside cells, and so it must invade cells to spread, Mahony explained. When the bacteria comes into contact with a cell, it secretes proteins that penetrate the cell and facilitate the process of invasion.

Out of 20 different proteins involved in the secretion system, the researchers identified three that are crucial to the process.

A vaccine created from these three proteins proved highly effective in protecting female mice from chlamydia, the researchers reported.

The team plans to perform a follow-up study in guinea pigs, and another in monkeys, before moving on to human trials, Mahony said. It will be at least four to five years before the vaccine can be tested in humans.

"It's going to take a number of years," he said. "This is just the first step, but it looks very, very promising."

Human trials for a chlamydia vaccine will be tricky, said Dr. Bruce Farber, chief of infectious diseases at North Shore University Hospital in Manhasset, N.Y., and Long Island Jewish Medical Center in New Hyde Park, N.Y.

"We're talking about many, many years of development and testing, particularly for a vaccine that's not going to be easy to test," Farber said. "Even though it's a fairly common sexually transmitted disease, it's not that common that it wouldn't take a long trial to get this done."

But if clinical trials are successful, the vaccine could be much more useful, Mahony said.

All strains of chlamydia use the same protein secretion process to invade cells, which means this vaccine should also protect against strains that cause blindness or pneumonia, Mahony explained.

The study is published July 29 in the journal Vaccine.

Article Credits / Source

Dennis Thompson / HealthDay

Dennis Thompson wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCES: James Mahony, Ph.D., professor, pathology and molecular medicine, Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario; Bruce Farber, M.D., chief, infectious diseases, North Shore University Hospital, Manhasset, N.Y., and Long Island Jewish Medical Center, New Hyde Park, N.Y.; July 29, 2016, Vaccine

View More Articles From Dennis Thompson 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Sexual Health Articles

Injections Might Help Prevent Genital Herpes Transmission for Months: Study

Injections Might Help Prevent Genital Herpes Transmission for Months: Study0

WEDNESDAY, Nov. 2, 2016 (HealthDay News) -- Three injections of a therapeutic vaccine may control genital herpes as effectively as daily pills for at least a year, a new study suggests. Researchers tested the experimental vaccine in 310 people ...

Genital Warts in Women (HPV)

Genital Warts in Women (HPV)0

Genital warts definition and facts Genital warts are caused by infection with a subgroup of the human papillomaviruses (HPVs). Another subgroup of the HPVs that infect the anogenital tract can lead to precancerous changes in the ...



Trichomoniasis facts* *Trichomoniasis facts Medically Edited by: Melissa Conrad Stöppler, MD Trichomoniasis is a sexually transmitted disease (STD) or sexually transmitted  infection (STI) caused by a parasite. Trichomonas ...

Male Birth Control in a Shot: Promising, But More Work Needed

Male Birth Control in a Shot: Promising, But More Work Needed0

THURSDAY, Oct. 27, 2016 (HealthDay News) -- A birth control shot for men shows some promise, but researchers are still struggling to improve its effectiveness and deal with severe side effects caused by the injections. Only four pregnancies ...

Sexually Transmitted Diseases Hit All-Time High: CDC

Sexually Transmitted Diseases Hit All-Time High: CDC0

WEDNESDAY, Oct. 19, 2016 (HealthDay News) -- Sexually transmitted disease (STD) cases reached a record high in the United States in 2015, federal officials reported Wednesday. There were more than 1.5 million chlamydia cases, nearly 400,000 ...

View More Sexual Health Articles


Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!